1 |
Jimenez DG, Altunbulakli C, Swoboda S, Sobti A, Askmyr D, Ali A, Greiff L, Lindstedt M. Single-cell analysis of myeloid cells in HPV+ tonsillar cancer. Front Immunol 2023;13. [DOI: 10.3389/fimmu.2022.1087843] [Reference Citation Analysis]
|
2 |
Rühle A, Todorovic J, Spohn SSK, Gkika E, Becker C, Knopf A, Zamboglou C, Sprave T, Werner M, Grosu A, Kayser G, Nicolay NH. Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy. Radiat Oncol 2022;17:181. [DOI: 10.1186/s13014-022-02153-9] [Reference Citation Analysis]
|
3 |
Jiang S, Li X, Huang L, Xu Z, Lin J. Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer. Front Immunol 2022;13:988416. [DOI: 10.3389/fimmu.2022.988416] [Reference Citation Analysis]
|
4 |
Borgmann M, Oetting A, Meyer F, Möckelmann N, Droste C, von Bargen CM, Möller-Koop C, Witt M, Borgmann K, Rothkamm K, Betz C, Münscher A, Clauditz TS, Rieckmann T. The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 2022. [PMID: 35941227 DOI: 10.1007/s00432-022-04244-2] [Reference Citation Analysis]
|